Followers | 1106 |
Posts | 279775 |
Boards Moderated | 10 |
Alias Born | 03/18/2011 |
![](https://investorshub.advfn.com/uicon/251916.png?cb=1471870726)
Tuesday, February 07, 2012 6:10:18 AM
~ $CGEN ~ Earnings expected on Tuesday *
This Week In Earnings: Earnings are coming or are already posted! This is what the charts look like! If you play the earnings these posts can be very helpful to you!
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.
![](http://investorshub.advfn.com/uimage/uploads/2012/2/1/fwzowearnings_bgd._MAINTOPlq.gif)
![](http://investorshub.advfn.com/uimage/uploads/2012/2/1/jlbqeearnings_Daily_main.gif)
http://stockcharts.com/h-sc/ui?s=CGEN&p=D&b=3&g=0&id=p88783918276&a=237480049
![](http://investorshub.advfn.com/uimage/uploads/2012/2/1/syhfsearnings_Weekly_main.gif)
http://stockcharts.com/h-sc/ui?s=CGEN&p=W&b=3&g=0&id=p54550695994
![](http://investorshub.advfn.com/uimage/uploads/2012/2/1/vggpjearnings_DD_links_main.gif)
![](http://investorshub.advfn.com/uimage/uploads/2011/12/1/lmxfjIhubimage2a0013.png)
![](http://investorshub.advfn.com/uimage/uploads/2011/12/1/wpgjdIhubimage2a0011.png)
![](http://investorshub.advfn.com/uimage/uploads/2011/12/1/eodpuIhubimage2a0006.jpg)
![](http://investorshub.advfn.com/uimage/uploads/2011/12/1/eodpuIhubimage2a0006.jpg)
![](http://investorshub.advfn.com/uimage/uploads/2011/12/1/atzffIhubimage2a0007.png)
![](http://investorshub.advfn.com/uimage/uploads/2011/12/1/atzffIhubimage2a0007.png)
![](http://investorshub.advfn.com/uimage/uploads/2011/12/1/ewitlIhubimage2a0014.png)
![](http://investorshub.advfn.com/uimage/uploads/2011/12/1/j[[dsIhubimage2a0009.png)
![](http://investorshub.advfn.com/uimage/uploads/2011/12/1/lqzjyIhubimage2a0008.png)
![](http://investorshub.advfn.com/uimage/uploads/2011/12/1/sgtpxihubsmall.jpg)
![](http://investorshub.advfn.com/uimage/uploads/2011/12/1/sgtpxihubsmall.jpg)
![](http://investorshub.advfn.com/uimage/uploads/2011/12/1/sgtpxihubsmall.jpg)
![](http://investorshub.advfn.com/uimage/uploads/2011/12/1/sgtpxihubsmall.jpg)
![](http://investorshub.advfn.com/uimage/uploads/2011/12/1/sgtpxihubsmall.jpg)
![](http://investorshub.advfn.com/uimage/uploads/2011/12/1/zniumIhubimage2a0010.png)
![](http://investorshub.advfn.com/uimage/uploads/2011/12/10/knm[dIhubimage2a0081.png)
![](http://investorshub.advfn.com/uimage/uploads/2011/12/10/knm[dIhubimage2a0081.png)
![](http://investorshub.advfn.com/uimage/uploads/2011/12/10/knm[dIhubimage2a0081.png)
![](http://investorshub.advfn.com/uimage/uploads/2011/12/10/knm[dIhubimage2a0081.png)
![](http://investorshub.advfn.com/uimage/uploads/2011/12/10/knm[dIhubimage2a0081.png)
![](http://investorshub.advfn.com/uimage/uploads/2012/2/1/vzyqeearnings_bgd._PM_ME_main2.gif)
http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916
*If the earnings date is in error please ignore error. I do my best.
My stuff http://investorshub.advfn.com/boards/read_msg.aspx?message_id=64797507
Never, invest with money you need to survive. Diversify, patience, set tight stops. $20 or less in commission fees is almost always cheaper than a 5-40%+ drop in share value.
Recent CGEN News
- Compugen to Present at Upcoming Antibody Industrial Symposium • PR Newswire (US) • 06/17/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/30/2024 11:00:12 AM
- Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig • PR Newswire (US) • 05/30/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/20/2024 11:00:07 AM
- Compugen Reports First Quarter 2024 Results • PR Newswire (US) • 05/20/2024 11:00:00 AM
- U.S. Index Futures Edge Slightly Higher in Pre-Market Trading, Oil Prices Dip • IH Market News • 05/20/2024 10:59:35 AM
- Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic Potential • PR Newswire (US) • 05/16/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/15/2024 11:02:08 AM
- Compugen Appoints David Silberman as Chief Financial Officer • PR Newswire (US) • 05/15/2024 11:00:00 AM
- Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024 • PR Newswire (US) • 05/06/2024 11:00:00 AM
- Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024 • PR Newswire (US) • 04/25/2024 11:00:00 AM
- Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503 • PR Newswire (US) • 04/10/2024 11:00:00 AM
- Compugen to Participate in Two Upcoming Investor Conferences • PR Newswire (US) • 04/03/2024 11:00:00 AM
- Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy • PR Newswire (US) • 03/11/2024 11:00:00 AM
- Compugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024 • PR Newswire (US) • 03/06/2024 12:00:00 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/05/2024 09:06:21 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/05/2024 12:00:24 PM
- Compugen Reports Fourth Quarter and Full Year 2023 Results • PR Newswire (US) • 03/05/2024 12:00:00 PM
- U.S. Futures Dip, Crude Oil Fluctuates • IH Market News • 03/05/2024 11:05:54 AM
- Compugen to Present at the Leerink Partners Global Biopharma Conference 2024 • PR Newswire (US) • 02/26/2024 12:00:00 PM
- Compugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024 • PR Newswire (US) • 02/20/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/15/2024 12:00:08 PM
- Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer • PR Newswire (US) • 02/15/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/08/2024 12:10:06 PM
- Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer • PR Newswire (US) • 01/08/2024 12:05:00 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM